Abstract:Lung cancer is a leading cause of mortality worldwide and despite recent improvements in lung cancer treatments patient mortality remains high. miR-193a-5p serves a crucial role in the initiation and development of cancer; it is necessary to understand the underlying molecular mechanisms of miR-193a-5p in lung cancer, which may enable the development of improved clinical diagnoses and therapies. The present study investigated the diagnostic value of peripheral blood and tissue miR-193a-5p expression using a microarray meta-analysis. Peripheral blood miR-193a-5p was revealed to be upregulated in patients with lung cancer. The pooled area under the curve (AUC) was 0.67, with a sensitivity and specificity of 0.74 and 0.56, respectively. Conversely, the peripheral tissue miR-193a-5p expression in patients with lung cancer was significantly downregulated. The pooled AUC was 0.83, and the sensitivity and specificity were 0.65 and 0.89, respectively. Through bioinformatics analysis, three Kyoto Encyclopedia of Genes and Genomes (KEGG) terms, pathways in cancer, prostate cancer and RIG-I-like receptor signaling pathway, were identified as associated with miR-193a-5p in lung cancer. In addition, in lung cancer, six key miR-193a-5p target genes, receptor tyrosine-protein kinase erbB-2 (ERBB2), nuclear cap-binding protein subunit 2 (NCBP2), collagen -1(I) chain (COL1A1), roprotein convertase subtilisin/kexin type 9 (PCSK9), casein kinase II subunit (CSNK2A1) and nucleolar transcription factor 1 (UBTF), were identified, five of which were significantly upregulated (ERBB2, NCBP2, COL1A1, CSNK2A1 and UBTF). The protein expression of ERBB2, NCBP2, COL1A1, CSNK2A1 and UBTF was also upregulated. NCBP2 and CSNK2A1 were negatively correlated with miR-193a-5p. The results demonstrated that miR-193a-5p exhibited opposite expression patterns in peripheral blood and tissue. Upregulated peripheral blood miR-193a-5p and downregulated tissue miR-193a-5p may be promising diagnostic biomarkers in lung cancer. In addition, the KEGG terms pathways in cancer, prostate cancer and RIG-I-like receptor signaling pathway may suggest which pathways serve vital roles in lung cancer by regulating miR-193a-5p. In addition, six genes, ERBB2, COL1A1, PCSK9, UBTF and particularly NCBP2 and CSNK2A1, may be key target genes of miR-193a-5p in lung cancer.

MiR-32 Suppresses the Development of Lung Cancer via Modulating PI3K/Akt

MiR-337 Suppresses Pancreatic Cancer Development Via STAT3/Wnt/β-catenin Axis.

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Investigation of Targeting Relationship Between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcinoma

MiR‐34b‐3p Represses Cell Proliferation, Cell Cycle Progression and Cell Apoptosis in Non‐small‐cell Lung Cancer (NSCLC) by Targeting CDK4

MiR-451 Suppresses Cell Proliferation and Metastasis in A549 Lung Cancer Cells

MicroRNA-374b Accelerates the Development of Lung Cancer Through Downregulating PTEN Expression Via Activating PI3K/Akt Pathway.

Decreased Expression Of Mir-32 Is Associated With The Clinical Outcome Of Non-Small Cell Lung Cancer Patients

Mir-550A-5p Functions As a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma

A systematic analysis of predicted MiR-31-targets identifies a diagnostic and prognostic signature for lung cancer.

Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299

Overexpression of mir-489-3p inhibits proliferation and migration of non-small cell lung cancer cells by suppressing the HER2/PI3K/AKT/Snail signaling pathway

MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer

MiR-1 Targets PIK3CA and Inhibits Tumorigenic Properties of A549 Cells.

miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3

MicroRNA-29c Functions As a Tumor Suppressor by Targeting VEGFA in Lung Adenocarcinoma

Mir-1301-3p Promotes the Proliferation and Migration of Lung Cancer Cells Via Direct Repression of Polymerase I and Transcript Release Factor.

A Meta-Analysis And Bioinformatics Exploration Of The Diagnostic Value And Molecular Mechanism Of Mir-193a-5p In Lung Cancer

miR-30b-5p inhibits cancer progression and enhances cisplatin sensitivity in lung cancer through targeting LRP8